Independent factors and predictive score for extrahepatic metastasis of hepatocellular carcinoma following curative hepatectomy

Oncologist

Volumn 17, Issue 7, 2012, Pages 963-969

  Jun, Li ^a   Zhenlin, Yan ^a   Renyan, Gong ^a   Yizhou, Wang ^a   Xuying, Wan ^a   Feng, Xue ^a   Yong, Xia ^a   Kui, Wang ^a   Jian, Liu ^a   Dong, Wu ^a   Hongyang, Wang ^a   Lehua, Shi ^a   Mengchao, Wu ^a   Feng, Shen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Extrahepatic metastasis; Hepatectomy; Hepatocellular carcinoma; Prediction; Risk factor

Indexed keywords

ALPHA FETOPROTEIN;

ADOLESCENT; ADULT; AGED; AHILD; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHILD; COHORT STUDIES; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 84864068513     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2011-0447     Document Type: Article

References (41)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249.
2. Lopez PM, Villanueva A, Llovet JM. Systematic review: Evidence-based management of hepatocellular carcinoma-an updated analysis of randomized controlled trials. Aliment Pharmacol Ther 2006;23:1535-1547.
3. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005;25:181-200.
4. Lee YT, Geer DA. Primary liver cancer: Pattern of metastasis. J Surg Oncol 1987;36:26-31.
5. Hong SS, Kim TK, Sung KB et al. Extrahepatic spread of hepatocellular carcinoma: A pictorial review. Eur Radiol 2003;13:874-882.
6. Katyal S, Oliver JH 3rd, Peterson MS et al. Extrahepatic metastases of hepatocellular carcinoma. Radiology 2000;216:698-703.
7. Yang Y, Nagano H, Ota H et al. Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. Surgery 2007;141:196-202.
8. 18Ffluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma. Oncology 2007;72(suppl 1):104-110.
9. Sun L, Guan YS, Pan WM et al. Positron emission tomography/computer tomography in guidance of extrahepatic hepatocellular carcinoma metastasis management. World J Gastroenterol 2007;13:5413-5415.
10. Nakajima J, Tanaka M, Matsumoto J et al. Appraisal of surgical treatment for pulmonary metastasis from hepatocellular carcinoma. World J Surg 2005;29: 715-718.
11. Chen F, Satok K, Fujinaga T et al. Pulmonary resection for metastases from hepatocellular carcinoma. World J Surg 2008;32:2213-2217.
12. Shuto T, Hirohashi K, Kubo S et al. Treatment of adrenal metastases after hepatic resection of a hepatocellular carcinoma. Dig Surg 2001;18:294-297.
13. Lo CM, Lai EC, Fan ST et al. Resection for extrahepatic recurrence of hepatocellular carcinoma. Br J Surg 1994;81:1019-1021.
14. Llovet JM, Ricci S, Mazzaferro V et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378-390.
15. Pinter M, Sieghart W, Graziadei I et al. Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis. The Oncologist 2009;14: 70-76.
16. Feng YX, Wang T, Deng YZ et al. Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model. Hepatology 2011;53:483-492.
17. Xiang ZL, Zeng ZC, Tang ZY et al. Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma. The Oncologist 2011;16:1028-1039.
18. Mann CD, Neal CP, Garcea G et al. Prognostic molecular markers in hepatocellular carcinoma: A systematic review. Eur J Cancer 2007;43:979-992.
19. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236.
20. Gwak GY, Jung JO, Sung SW et al. Long-term survival after pulmonary metastatectomy of hepatocellular carcinoma: Treatment outcome or natural history? Hepatogastroenterology 2004;51:1428-1433.
21. Taketomi A, Toshima T, Kitagawa D et al. Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 2010;17:2740-2746.
22. Hastie T, Tibshirani R, Friedman J, eds. The Elements of Statistical Learning, First Edition. New York: Springer, 2001:214-217.
23. Yuen MF, Tanaka Y, Fong DY et al. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatology 2009;50:80-88.
24. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000;56:337-344.
25. Galen RS. Application of the predictive value model in the analysis of test effectiveness. Clin Lab Med 1982;2:685-699.
26. Gould WW. sg34: Jackknife estimation. In: Stata Technical Bulletin 24. College Station, TX: Stata Press, 1995:25-29.
27. Portolani N, Coniglio A, Ghidoni S et al. Early and late recurrence after liver resection for hepatocellular carcinoma: Prognostic and therapeutic implications. Ann Surg 2006;243:229-235.
28. Cucchetti A, Piscaglia F, Caturelli E et al. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. Ann Surg Oncol 2009; 16:413-422.
29. Hart IR. The spread of tumors. In: Franks L, Teich N, eds. Cellular and Molecular Biology of Cancer. Oxford, U.K.: Oxford University Press, 1997:21-23.
30. Grigioni WF, D'Errico A, Biagini G et al. The capsule surrounding primary liver tumors: Wherefrom its prognostic significance? Int J Cancer 1990;45:637-643.
31. Ishizaki M, Ashida K, Higashi T et al. The formation of capsule and septum in human hepatocellular carcinoma. Virchows Arch 2001;438:574-580.
32. Ng IO, Lai EC, Ng MM et al. Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer 1992;70:45-49.
33. Iguchi T, Aishima S, Sanefuji K et al. Both fibrous capsule formation and extracapsular penetration are powerful predictors of poor survival in human hepatocellular carcinoma: A histological assessment of 365 patients in Japan. Ann Surg Oncol 2009;16:2539-2546.
34. Edge SB, Carducci MA, Compton CC et al., eds. AJCC Cancer Staging Manual, Seventh Edition. Chicago: Springer, 2009:237.
35. Forner A, Reig ME, de Lope CR et al. Current strategy for staging and treatment: The BCLC update and future prospects. Semin Liver Dis 2010;30:61-74.
36. Nagao T, Inoue S, Goto S et al. Hepatic resection for hepatocellular carcinoma. Clinical features and longterm prognosis. Ann Surg 1987;205:33-40.
37. Tanaka T, Yamanaka N, Oriyama T et al. Factors regulating tumor pressure in hepatocellular carcinoma and implications for tumor spread. Hepatology 1997;26: 283-287.
38. Cucchetti A, Piscaglia F, Grigioni AD et al. Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: A pilot study. J Hepatol 2010;52:880-888.
39. Koide N, Hanazaki K, Fujimori Y et al. Synchronous gastric cancer associated with hepatocellular carcinoma: A study of 10 patients. Hepatogastroenterology 1999;46:3008-3014.
40. Wong LL, Lurie F, Takanishi DM Jr. Other primary neoplasms in patients with hepatocellular cancer: Prognostic implications? Hawaii Med J 2007;66:204, 206-208.
41. Fernandez-Ruiz M, Guerra-Vales JM, Castelbon-Fernandez FJ et al. Multiple primary malignancies in Spanish patients with hepatocellular carcinoma: Analysis of a hospital-based tumor registry. J Gastroenterol Hepatol 2009;24:1424-1430.